Nemours Foundation Report issue

Foundation Phase 1 Phase 2 Phase 3

Organization Overview

First Clinical Trial
2009
NCT00915902
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Nemours